GYRE vs UHS · rev $53.5M vs P/E 5.9, rev $9.13B
Gyre Therapeutics Inc. (GYRE) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
GYRE currently screens at market cap $589.9M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the GYRE and UHS stock pages for the full models.
Not investment advice.